Schistosomiasis, certainly one of 17 illnesses deemed to be uncared for by the World Well being Group, has acquired little consideration from the biopharmaceutical business. As a result of this, solely a handful of medication have been developed to deal with schistosomiasis, with just one, praziquantel, utilized in most endemic areas. Rising concern over resistance coupled with praziquantel’s incomplete efficacy throughout all phases of the Schistosoma platyhelminth life cycle highlights the pressing want for brand spanking new medication.
The WIPO Re:Search consortium is a platform whereupon biopharmaceutical firm compounds are being repurposed to effectively and cost-effectively develop new medication for uncared for illnesses resembling schistosomiasis. This text summarizes latest clinical-stage efforts to determine new antischistosomals and highlights biopharmaceutical firm compounds with potential for repurposing to deal with schistosomiasis.
Flavonoids on the pharma-nutrition interface: Is a therapeutic index in demand?
The consumption of flavonoid-rich meals may have useful results on well being. Nevertheless, totally different lessons of flavonoids have totally different impact on illness threat and the connection between flavonoid consumption and threat of illness seemed to be non-linear. Moreover, contrarily to nutritional vitamins, there aren’t any signs of deficiency for flavonoids; due to this fact, our physique treats them like different xenobiotics. Due to this fact, a therapeutic index must be decided. Regardless of flavonoids are on the pharma-nutrition interface, medication and meals are topic to totally different regulatory frameworks and there’s no really helpful each day allowance (RDA) for flavonoids.
Comparatively little is understood in regards to the efficacy, security and underlying mechanisms of those bioactive compounds, particularly when taken in live performance with medication. Flavonoids may act each as medication and pro-drugs with pharmacological and toxicological promiscuity. As a result of low bioavailability, the gastrointestinal tract may very well be the first goal of flavonoids and metabolites. Completely different results have been noticed after acute and power consumption and bioavailability and bioactivity have excessive inter-individual variability.
Moreover, the difficulties within the design and within the interpretation of human intervention research make troublesome the institution of a therapeutic index for flavonoids. Most likely the idea of ‘personalised diet’ beforehand proposed may very well be the higher strategy. Nevertheless, regardless of extra research are wanted with the intention to set up a therapeutic index for every flavonoid subclasses, for the time being RDA of whole flavonoids may very well be between 250-400 mg/d, respecting the seasonality of meals sources.
High quality compliance within the shift from cell transplantation to cell remedy in non-pharma environments.
Together with educational and charitable organizations, transfusion facilities have ventured into the stem cell discipline, with the intention of testing of novel cell-based therapeutics in a scientific setting for future advertising and marketing approval. The truth that high quality administration constructions, that are required for compliance with good scientific follow rules, have been initially designed for product improvement in company environments represents a serious problem for a lot of builders. On this Commentary, challenges that non-pharmaceutical establishments should overcome to translate cell-based merchandise into scientific therapies can be mentioned from a high quality standpoint. Moreover, our improvement expertise for a mesenchymal stromal cell-based remedy can be shared as a case research.
Nanomedicine: a pharma perspective.
Nanotechnology as utilized to drugs is just not a brand new discipline. The primary nanomedicines accredited to be used have been developed from analysis relationship again to the 1970s. These liposomal formulations of current medication confirmed improved therapeutic exercise and decreased toxicity within the nonclinical mannequin methods. Nevertheless, these advantages proved extra refined and tougher to show in sufferers. This reality, mixed with the technical challenges in commercial-scale manufacturing of nanoparticles, led to solely restricted funding in nanomedicines by the key pharmaceutical corporations.
Even so, analysis on nanomedicines has proceeded apace in educational laboratories and smaller biopharmaceutical corporations. New supplies and drug mixtures have been studied, and concentrating on moieties added with the intention of enhancing the therapeutic index. Right now many of those new designs are in, or are approaching, scientific testing. It’ll take just one or two to achieve success to vary the best way pharmaceutical corporations view this discipline of revolutionary analysis.
Evaluation of (poly)phenols in grape (Vitis vinifera L.) stems through the use of meals/pharma business suitable solvents and Response Floor Methodology.
A Field-Behnken design of Response Floor Methodology (RSM) was carried out to analyse the impact of time (10-30 min), temperature (25-95°C), and solvents focus (5-90%) on the extraction of whole phenolics, flavonoids, ortho-diphenols, and anthocyanins in addition to to evaluate the ABTS(+) scavenging capability, which have been thought-about as response variables. Values coefficients of willpower (R(2)), starting from 0.903 to 0.996, fitted for describing environment friendly extraction of bioactive (poly)phenols and antioxidant exercise. The recorded knowledge allowed to ascertain the optimum extraction situations at 23.Zero min, 95.0°C, and 57.9% of food-quality ethanol/water for Vitis vinifera L. var.
) Mixture ME 250 (European Pharm) |
|
MBS394010-5x100mg |
MyBiosource |
5x100mg |
EUR 895 |
) Mixture ME 251 (European Pharm) |
|
MBS394011-100mg |
MyBiosource |
100mg |
EUR 295 |
Mixture ME 251 (European Pharm) |
|
MBS394011-5x100mg |
MyBiosource |
5x100mg |
EUR 920 |
) Mixture ME 291 (European Pharm) |
|
MBS394017-1g |
MyBiosource |
1g |
EUR 390 |
Mixture ME 291 (European Pharm) |
|
MBS394017-5x1g |
MyBiosource |
5x1g |
EUR 1370 |
) Mixture ME 450 (European Pharm) |
|
MBS394024-100mg |
MyBiosource |
100mg |
EUR 265 |
Mixture ME 450 (European Pharm) |
|
MBS394024-5x100mg |
MyBiosource |
5x100mg |
EUR 800 |
) Mixture ME 451 (European Pharm) |
|
MBS394025-100mg |
MyBiosource |
100mg |
EUR 270 |
Mixture ME 451 (European Pharm) |
|
MBS394025-5x100mg |
MyBiosource |
5x100mg |
EUR 820 |
) Recombinant European elk papillomavirus Protein E5 (E5) |
|
MBS1218112-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 970 |
Recombinant European elk papillomavirus Protein E5 (E5) |
|
MBS1218112-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 525 |
Recombinant European elk papillomavirus Protein E5 (E5) |
|
MBS1218112-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 720 |
Recombinant European elk papillomavirus Protein E5 (E5) |
|
MBS1218112-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 625 |
Recombinant European elk papillomavirus Protein E5 (E5) |
|
MBS1218112-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 845 |
) Recombinant European elk papillomavirus Protein E7 (E7) |
|
MBS1144614-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1025 |
Recombinant European elk papillomavirus Protein E7 (E7) |
|
MBS1144614-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 600 |
Recombinant European elk papillomavirus Protein E7 (E7) |
|
MBS1144614-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 780 |
Recombinant European elk papillomavirus Protein E7 (E7) |
|
MBS1144614-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 695 |
Recombinant European elk papillomavirus Protein E7 (E7) |
|
MBS1144614-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 910 |
) Recombinant European elk papillomavirus Protein E6 (E6) |
|
MBS1103713-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1055 |
Recombinant European elk papillomavirus Protein E6 (E6) |
|
MBS1103713-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 640 |
Recombinant European elk papillomavirus Protein E6 (E6) |
|
MBS1103713-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 810 |
Recombinant European elk papillomavirus Protein E6 (E6) |
|
MBS1103713-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 745 |
Recombinant European elk papillomavirus Protein E6 (E6) |
|
MBS1103713-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 950 |
 Vornado™ miniature vortex mixer with red cup head, 100 to 240V with European Plug Adapter |
|
BV101-R-E |
Benchmark Scientific |
1 PC |
EUR 229.09 |
 European Cuscuta TaqProbe qPCR. 100 RXN |
|
TBS42009-100 |
Tribioscience |
100 RXN |
EUR 1100 |
 European Cuscuta TaqProbe qPCR. 50 RXN |
|
TBS42009-50 |
Tribioscience |
50 RXN |
EUR 600 |
 STREPTAVIDIN: Texas Red Reagent |
|
GWB-Q00343 |
GenWay Biotech |
1 mg |
Ask for price |
) Recombinant European elk papillomavirus Minor capsid protein L2 (L2) |
|
MBS1233970-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1345 |
Recombinant European elk papillomavirus Minor capsid protein L2 (L2) |
|
MBS1233970-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 1040 |
Recombinant European elk papillomavirus Minor capsid protein L2 (L2) |
|
MBS1233970-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1140 |
Recombinant European elk papillomavirus Minor capsid protein L2 (L2) |
|
MBS1233970-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1215 |
Recombinant European elk papillomavirus Minor capsid protein L2 (L2) |
|
MBS1233970-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1295 |
 Automatic Decapper, European/German Standard Plug |
|
107001 |
NEST Biotechnology |
1 pcs/cs |
EUR 5018.31 |
|
Description: Automatic Decapper, European/German Standard Plug |
) L.R. White Embedding Media (for European Orders only) |
|
17411H-500 |
Polysciences Europe GmbH |
500ml |
EUR 227.88 |
|
Description: 7732-18-5 |
L.R. White Embedding Media (for European Orders only) |
|
17411HUNC-500 |
Polysciences Europe GmbH |
500ml |
EUR 318.6 |
|
Description: 7732-18-5 |
L.R. White Embedding Media (for European Orders only) |
|
17411M-500 |
Polysciences Europe GmbH |
500ml |
EUR 227.88 |
|
Description: 7732-18-5 |
L.R. White Embedding Media (for European Orders only) |
|
17411MUNC-500 |
Polysciences Europe GmbH |
500ml |
EUR 318.6 |
|
Description: 7732-18-5 |
L.R. White Embedding Media (for European Orders only) |
|
17411S-500 |
Polysciences Europe GmbH |
500ml |
EUR 227.88 |
|
Description: 7732-18-5 |
L.R. White Embedding Media (for European Orders only) |
|
17411SUNC-500 |
Polysciences Europe GmbH |
500ml |
EUR 318.6 |
|
Description: 7732-18-5 |
, partial) Recombinant European elk papillomavirus Replication protein E1 (E1), partial |
|
MBS1217249-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
) Recombinant European elk papillomavirus Probable regulatory protein E2 (E2) |
|
MBS1040198-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1285 |
Recombinant European elk papillomavirus Probable regulatory protein E2 (E2) |
|
MBS1040198-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 965 |
Recombinant European elk papillomavirus Probable regulatory protein E2 (E2) |
|
MBS1040198-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1080 |
Recombinant European elk papillomavirus Probable regulatory protein E2 (E2) |
|
MBS1040198-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1125 |
Recombinant European elk papillomavirus Probable regulatory protein E2 (E2) |
|
MBS1040198-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1230 |
) Immortalized European Sea Bass Brain Cells (DLB-1) |
|
T0730 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
, partial) Recombinant European elk papillomavirus Major capsid protein L1 (L1), partial |
|
MBS1066977-005mgBaculovirus |
MyBiosource |
0.05mg(Baculovirus) |
EUR 1270 |
Recombinant European elk papillomavirus Major capsid protein L1 (L1), partial |
|
MBS1066977-005mgEColi |
MyBiosource |
0.05mg(E-Coli) |
EUR 1070 |
Recombinant European elk papillomavirus Major capsid protein L1 (L1), partial |
|
MBS1066977-02mgEColi |
MyBiosource |
0.2mg(E-Coli) |
EUR 1390 |
Recombinant European elk papillomavirus Major capsid protein L1 (L1), partial |
|
MBS1066977-02mgYeast |
MyBiosource |
0.2mg(Yeast) |
EUR 1515 |
Recombinant European elk papillomavirus Major capsid protein L1 (L1), partial |
|
MBS1066977-05mgEColi |
MyBiosource |
0.5mg(E-Coli) |
EUR 1530 |
) Recombinant European bat lyssavirus 2 Nucleoprotein (N) |
|
MBS1172355-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1320 |
Recombinant European bat lyssavirus 2 Nucleoprotein (N) |
|
MBS1172355-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 1010 |
Recombinant European bat lyssavirus 2 Nucleoprotein (N) |
|
MBS1172355-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1115 |
Recombinant European bat lyssavirus 2 Nucleoprotein (N) |
|
MBS1172355-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1175 |
Recombinant European bat lyssavirus 2 Nucleoprotein (N) |
|
MBS1172355-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1265 |
) Recombinant European bat lyssavirus 1 Nucleoprotein (N) |
|
MBS1034145-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1320 |
Recombinant European bat lyssavirus 1 Nucleoprotein (N) |
|
MBS1034145-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 1010 |
Recombinant European bat lyssavirus 1 Nucleoprotein (N) |
|
MBS1034145-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1115 |
Recombinant European bat lyssavirus 1 Nucleoprotein (N) |
|
MBS1034145-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1175 |
Recombinant European bat lyssavirus 1 Nucleoprotein (N) |
|
MBS1034145-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1265 |
) Recombinant European bat lyssavirus 2 Phosphoprotein (P) |
|
MBS1192580-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1175 |
Recombinant European bat lyssavirus 2 Phosphoprotein (P) |
|
MBS1192580-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 820 |
Recombinant European bat lyssavirus 2 Phosphoprotein (P) |
|
MBS1192580-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 965 |
Recombinant European bat lyssavirus 2 Phosphoprotein (P) |
|
MBS1192580-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 985 |
Recombinant European bat lyssavirus 2 Phosphoprotein (P) |
|
MBS1192580-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1130 |
) Recombinant European bat lyssavirus 1 Phosphoprotein (P) |
|
MBS1030114-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1180 |
Recombinant European bat lyssavirus 1 Phosphoprotein (P) |
|
MBS1030114-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 820 |
Recombinant European bat lyssavirus 1 Phosphoprotein (P) |
|
MBS1030114-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 965 |
Recombinant European bat lyssavirus 1 Phosphoprotein (P) |
|
MBS1030114-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 985 |
Recombinant European bat lyssavirus 1 Phosphoprotein (P) |
|
MBS1030114-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1130 |
) Recombinant European bat lyssavirus 2 Matrix protein (M) |
|
MBS1168808-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1120 |
Recombinant European bat lyssavirus 2 Matrix protein (M) |
|
MBS1168808-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 705 |
Recombinant European bat lyssavirus 2 Matrix protein (M) |
|
MBS1168808-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 875 |
Recombinant European bat lyssavirus 2 Matrix protein (M) |
|
MBS1168808-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 845 |
Recombinant European bat lyssavirus 2 Matrix protein (M) |
|
MBS1168808-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1025 |
) Recombinant European bat lyssavirus 1 Matrix protein (M) |
|
MBS1219199-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1120 |
Recombinant European bat lyssavirus 1 Matrix protein (M) |
|
MBS1219199-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 705 |
Recombinant European bat lyssavirus 1 Matrix protein (M) |
|
MBS1219199-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 875 |
Recombinant European bat lyssavirus 1 Matrix protein (M) |
|
MBS1219199-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 845 |
Recombinant European bat lyssavirus 1 Matrix protein (M) |
|
MBS1219199-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1025 |
 Viscotoxin-A3) Recombinant Viscum album (European mistletoe) Viscotoxin-A3 |
|
MBS1102241-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 375 |
Recombinant Viscum album (European mistletoe) Viscotoxin-A3 |
|
MBS1102241-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 420 |
Recombinant Viscum album (European mistletoe) Viscotoxin-A3 |
|
MBS1102241-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 635 |
Recombinant Viscum album (European mistletoe) Viscotoxin-A3 |
|
MBS1102241-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 695 |
Recombinant Viscum album (European mistletoe) Viscotoxin-A3 |
|
MBS1102241-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 1925 |
) Recombinant European bat lyssavirus 2 Glycoprotein G (G) |
|
MBS1114227-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
) Recombinant European bat lyssavirus 1 Glycoprotein G (G) |
|
MBS1087885-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant European bat lyssavirus 1 Glycoprotein G (G) |
|
MBS7037638-002mg |
MyBiosource |
0.02mg |
EUR 1855 |
Recombinant European bat lyssavirus 1 Glycoprotein G (G) |
|
MBS7037638-01mg |
MyBiosource |
0.1mg |
EUR 2785 |
Recombinant European bat lyssavirus 1 Glycoprotein G (G) |
|
MBS7037638-5x01mg |
MyBiosource |
5x0.1mg |
EUR 12495 |
Recombinant European bat lyssavirus 2 Glycoprotein G (G) |
|
MBS7037639-002mg |
MyBiosource |
0.02mg |
EUR 1855 |
Recombinant European bat lyssavirus 2 Glycoprotein G (G) |
|
MBS7037639-01mg |
MyBiosource |
0.1mg |
EUR 2785 |
Recombinant European bat lyssavirus 2 Glycoprotein G (G) |
|
MBS7037639-5x01mg |
MyBiosource |
5x0.1mg |
EUR 12495 |
) OPCA04490-100UG - THI2.1 Recombinant Protein (European mistletoe) |
|
OPCA04490-100UG |
Aviva Systems Biology |
100ug |
EUR 668 |
|
|
) OPCA04490-20UG - THI2.1 Recombinant Protein (European mistletoe) |
|
OPCA04490-20UG |
Aviva Systems Biology |
20ug |
EUR 449 |
|
|
 Congo Red |
|
21770010-1 |
Bio-WORLD |
100 g |
EUR 89.55 |
|
|
Congo Red |
|
21770010-2 |
Bio-WORLD |
25 g |
EUR 39.89 |
|
|
Congo Red |
|
B7766-1000 |
ApexBio |
1g |
EUR 89.6 |
|
|
|
Description: Membrane Transporter/Ion Channel|Glutamate (EAAT) Transporters |
Congo Red |
|
B7766-5.1 |
ApexBio |
10mM (in 1mL DMSO) |
EUR 65.6 |
|
|
|
Description: Membrane Transporter/Ion Channel|Glutamate (EAAT) Transporters |
Congo Red |
|
B7766-50 |
ApexBio |
50 mg |
EUR 154.8 |
Congo Red |
|
B7766-500 |
ApexBio |
500mg |
EUR 60 |
|
|
|
Description: Membrane Transporter/Ion Channel|Glutamate (EAAT) Transporters |
) MyFuge™12 Mini Centrifuge 100-240V (European 2 prong plug) |
|
C1012-E |
Benchmark Scientific |
1 PC |
EUR 457.47 |
 Annexin V-Elab Fluor® Red 780 Reagent |
|
E-CK-A139-100Tests |
Elabscience Biotech |
100 Tests |
EUR 190 |
|
|
|
Description: Apoptosis/Annexin V |
Annexin V-Elab Fluor® Red 780 Reagent |
|
E-CK-A139-200Tests |
Elabscience Biotech |
200 Tests |
EUR 298 |
|
|
|
Description: Apoptosis/Annexin V |
Annexin V-Elab Fluor® Red 780 Reagent |
|
E-CK-A139-500Tests |
Elabscience Biotech |
500 Tests |
EUR 660 |
|
|
|
Description: Apoptosis/Annexin V |
Annexin V-Elab Fluor® Red 780 Reagent |
|
E-CK-A139-50Tests |
Elabscience Biotech |
50 Tests |
EUR 110 |
|
|
|
Description: Apoptosis/Annexin V |
) Incu-Mixer MP2™ Heated Plate Vortexer 115-240V European plug) |
|
H6002-E |
Benchmark Scientific |
1 PC |
EUR 2032.55 |
, partial) Recombinant European bat lyssavirus 2 Glycoprotein G (G), partial |
|
MBS7064348-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1310 |
Recombinant European bat lyssavirus 2 Glycoprotein G (G), partial |
|
MBS7064348-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 995 |
Recombinant European bat lyssavirus 2 Glycoprotein G (G), partial |
|
MBS7064348-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1100 |
Recombinant European bat lyssavirus 2 Glycoprotein G (G), partial |
|
MBS7064348-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1160 |
Recombinant European bat lyssavirus 2 Glycoprotein G (G), partial |
|
MBS7064348-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1255 |
, partial) Recombinant European bat lyssavirus 1 Glycoprotein G (G), partial |
|
MBS7064410-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
) OPCA04190-1MG - Tropomyosin Recombinant Protein (European house dust mite) |
|
OPCA04190-1MG |
Aviva Systems Biology |
1mg |
EUR 1977 |
|
|
) OPCA04190-20UG - Tropomyosin Recombinant Protein (European house dust mite) |
|
OPCA04190-20UG |
Aviva Systems Biology |
20ug |
EUR 400 |
|
|
) OPCA04190-100UG - Tropomyosin Recombinant Protein (European house dust mite) |
|
OPCA04190-100UG |
Aviva Systems Biology |
100ug |
EUR 586 |
|
|
 Congo Red 1% |
|
40340025-1 |
Bio-WORLD |
8 oz |
EUR 38.15 |
) Recombinant allergen Bet v 1 for Betula verrucosa (European white birch) |
|
MBS505092-1mg |
MyBiosource |
1mg |
EUR 1080 |
Recombinant allergen Bet v 1 for Betula verrucosa (European white birch) |
|
MBS505092-5x1mg |
MyBiosource |
5x1mg |
EUR 4575 |
) Recombinant allergen Bet v 4 for Betula verrucosa (European white birch) |
|
MBS505093-1mg |
MyBiosource |
1mg |
EUR 1080 |
Recombinant allergen Bet v 4 for Betula verrucosa (European white birch) |
|
MBS505093-5x1mg |
MyBiosource |
5x1mg |
EUR 4575 |
 Vornado™ miniature vortexer, grey cup head, 100 to 240V with European Plug |
|
BV101-E |
Benchmark Scientific |
1 PC |
EUR 229.09 |
 Tropomyosin) Recombinant Dermatophagoides pteronyssinus (European house dust mite) Tropomyosin |
|
MBS1242430-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 375 |
Recombinant Dermatophagoides pteronyssinus (European house dust mite) Tropomyosin |
|
MBS1242430-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 635 |
Recombinant Dermatophagoides pteronyssinus (European house dust mite) Tropomyosin |
|
MBS1242430-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 1925 |
Recombinant Dermatophagoides pteronyssinus (European house dust mite) Tropomyosin |
|
MBS1242430-5x1mgEColi |
MyBiosource |
5x1mg(E-Coli) |
EUR 8405 |
 Congo Red Powder |
|
abx090680-100l |
Abbexa |
100 µl |
EUR 137.5 |
Congo Red Powder |
|
abx090680-1ml |
Abbexa |
1 ml |
Ask for price |
Congo Red Powder |
|
abx090680-200l |
Abbexa |
200 µl |
Ask for price |
Congo Red Powder |
|
abx090680-5g |
Abbexa |
5 g |
EUR 226.8 |
|
|
) Recombinant European mountain ash ringspot-associated virus Nucleoprotein (N) |
|
MBS1396562-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1190 |
Recombinant European mountain ash ringspot-associated virus Nucleoprotein (N) |
|
MBS1396562-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 840 |
Recombinant European mountain ash ringspot-associated virus Nucleoprotein (N) |
|
MBS1396562-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 980 |
Recombinant European mountain ash ringspot-associated virus Nucleoprotein (N) |
|
MBS1396562-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1010 |
Recombinant European mountain ash ringspot-associated virus Nucleoprotein (N) |
|
MBS1396562-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1115 |
 (Betula verrucosa) Profilin-1) Recombinant Betula pendula (European white birch) (Betula verrucosa) Profilin-1 |
|
MBS1134548-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 375 |
Recombinant Betula pendula (European white birch) (Betula verrucosa) Profilin-1 |
|
MBS1134548-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 635 |
Recombinant Betula pendula (European white birch) (Betula verrucosa) Profilin-1 |
|
MBS1134548-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 1925 |
Recombinant Betula pendula (European white birch) (Betula verrucosa) Profilin-1 |
|
MBS1134548-5x1mgEColi |
MyBiosource |
5x1mg(E-Coli) |
EUR 8405 |
, partial) Recombinant European brown hare syndrome virus Genome polyprotein (ORF1), partial |
|
MBS1429288-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
 Congo red, Certified |
|
GRM508-10G |
EWC Diagnostics |
1 unit |
EUR 14.01 |
|
Description: Congo red, Certified |
Congo red, Certified |
|
GRM508-25G |
EWC Diagnostics |
1 unit |
EUR 30.77 |
|
Description: Congo red, Certified |
 Peptidase 1) Recombinant Dermatophagoides pteronyssinus (European house dust mite) Peptidase 1 |
|
MBS1074396-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 375 |
Recombinant Dermatophagoides pteronyssinus (European house dust mite) Peptidase 1 |
|
MBS1074396-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 635 |
Recombinant Dermatophagoides pteronyssinus (European house dust mite) Peptidase 1 |
|
MBS1074396-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 1925 |
Recombinant Dermatophagoides pteronyssinus (European house dust mite) Peptidase 1 |
|
MBS1074396-5x1mgEColi |
MyBiosource |
5x1mg(E-Coli) |
EUR 8405 |
 Reagent) ERYTHROLYSE RED BLOOD CELL LYSING BUFFER (10x) Reagent |
|
GWB-Q00311 |
GenWay Biotech |
100 TEST/20ml |
Ask for price |
ERYTHROLYSE RED BLOOD CELL LYSING BUFFER (10x) Reagent |
|
GWB-Q00312 |
GenWay Biotech |
500 TESTS/100ml |
Ask for price |
 Recombinant European mountain ash ringspot-associated virus Envelope glycoprotein |
|
MBS7037640-002mg |
MyBiosource |
0.02mg |
EUR 1785 |
Recombinant European mountain ash ringspot-associated virus Envelope glycoprotein |
|
MBS7037640-01mg |
MyBiosource |
0.1mg |
EUR 2720 |
Recombinant European mountain ash ringspot-associated virus Envelope glycoprotein |
|
MBS7037640-5x01mg |
MyBiosource |
5x0.1mg |
EUR 12205 |
 Envelope protein E, His Tag (HPLC verified)) TBEV (European subtype, strain Neudoerfl) Envelope protein E, His Tag (HPLC verified) |
|
ENE-T52H4 |
ACROBIOSYSTEMS |
500ug |
EUR 490.5 |
|
|
|
Description: TBEV (European subtype, strain Neudoerfl) Envelope protein E, His Tag (ENE-T52H4) is expressed from human 293 cells (HEK293). It contains AA Ser 281-Lys 675 (Accession # P14336). |
TBEV (European subtype, strain Neudoerfl) Envelope protein E, His Tag (HPLC verified) |
|
ENE-T52H4-500ug |
ACROBIOSYSTEMS |
500ug |
EUR 3084.7 |
|
|
|
Description: TBEV (European subtype, strain Neudoerfl) Envelope protein E, His Tag (ENE-T52H4) is expressed from human 293 cells (HEK293). It contains AA Ser 281-Lys 675 (Accession # P14336). |
TBEV (European subtype, strain Neudoerfl) Envelope protein E, His Tag (HPLC verified) |
|
ENE-T52H4-50ug |
ACROBIOSYSTEMS |
50ug |
EUR 490.5 |
|
|
|
Description: TBEV (European subtype, strain Neudoerfl) Envelope protein E, His Tag (ENE-T52H4) is expressed from human 293 cells (HEK293). It contains AA Ser 281-Lys 675 (Accession # P14336). |
 Orbi-Shaker™Jr with rubber mat platform (9.5"x8"), 100-240V (European 2 prong plug) |
|
BT302-E |
Benchmark Scientific |
1 PC |
EUR 1205.74 |
, partial) Recombinant European bat lyssavirus 1 RNA-directed RNA polymerase L (L), partial |
|
MBS1243881-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
, partial) Recombinant European bat lyssavirus 2 RNA-directed RNA polymerase L (L), partial |
|
MBS1137468-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
 BenchWaver™ 3D Rocker with flat mat, 13.5x13" platform, 100-240V (European 2 prong plug) |
|
B3D5000-E |
Benchmark Scientific |
1 PC |
EUR 1548.97 |
 Recombinant Tick-borne encephalitis virus European subtype Genome polyprotein, partial |
|
CSB-EP318509TEM |
Cusabio |
11863 mg |
Ask for price |
Recombinant Tick-borne encephalitis virus European subtype Genome polyprotein, partial |
|
CSB-EP318509TEM-100ug |
Cusabio |
100ug |
Ask for price |
|
|
|
Description: 281-727aa |
‘Viosinho’ (white selection), and 23.four min, 84.2°C, and 63.8% for var. ‘Touriga Nacional’ (pink selection). The achievement of optimum extraction situations of phenolics from grape stems utilizing solvents suitable with additional makes use of in meals/pharma industries demonstrated that RSM constitutes a robust device for deriving optimum situations for extraction of antioxidant phenolic compounds from grape stems.
